Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra to Prevent Osteoarthritis After ACL Injury
NCT03968913Phase 1Recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Sep 2021
- Primary completion
- Jan 2027
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of anakinra in osteoarthritis (OA) (2 arms), sponsored by University of California, Los Angeles. Primary endpoints: Cytokine level analysis of synovial fluid and Cartilage biomarker analysis of synovial fluid. Started Sep 2021; status: recruiting.
02
Drugs
anakinra
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03968913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03968913.